ACTINIUM PHARMACEUTICALS, INC. Depreciation
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Depreciation of $173.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-30
- ACTINIUM PHARMACEUTICALS, INC. depreciation for the quarter ending 2018-12-31 was $12.66K, a 31.36% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for the quarter ending 2018-09-30 was $13.28K, a 20.24% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for the quarter ending 2018-06-30 was $12.82K, a 10.60% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for the quarter ending 2018-03-31 was $11.96K, a 42.81% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for fiscal 2025 was $173.00K, a 12.18% decline from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $197.00K, a 4.83% decline from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $207.00K, a 36.18% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $152.00K, a 44.76% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $173.00K 10-K · filed 2026-03-30 | ||||
| 2024-12-31 | $197.00K 10-K · filed 2026-03-30 | ||||
| 2023-12-31 | $207.00K 10-K · filed 2025-03-31 | ||||
| 2022-12-31 | $152.00K 10-K · filed 2024-03-29 | ||||
| 2021-12-31 | $105.00K 10-K · filed 2023-03-31 | ||||
| 2020-12-31 | $54.00K 10-K · filed 2022-03-25 | ||||
| 2019-12-31 | $54.00K 10-K · filed 2021-03-31 | $53.48K 10-K · filed 2020-05-08 | |||
| 2018-12-31 | $12.66K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | $25.94K derived: sum of 2 quarters · filed 2020-05-08 | $38.76K derived: sum of 3 quarters · filed 2020-05-08 | $50.72K 10-K · filed 2020-05-08 | |
| 2018-09-30 | $13.28K 10-Q · filed 2018-11-09 | $26.10K derived: sum of 2 quarters · filed 2018-11-09 | $38.06K 10-Q · filed 2018-11-09 | $47.70K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2018-06-30 | $12.82K 10-Q · filed 2018-08-09 | $24.78K 10-Q · filed 2018-08-09 | $34.41K derived: sum of 3 quarters · filed 2019-03-15 | $45.46K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2018-03-31 | $11.96K 10-Q · filed 2018-05-10 | $21.60K derived: sum of 2 quarters · filed 2019-03-15 | $32.65K derived: sum of 3 quarters · filed 2019-03-15 | $46.98K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-12-31 | $9.63K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $20.68K derived: sum of 2 quarters · filed 2019-03-15 | $35.02K derived: sum of 3 quarters · filed 2019-03-15 | $55.94K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $11.05K 10-Q · filed 2018-11-09 | $25.38K derived: sum of 2 quarters · filed 2018-11-09 | $46.30K 10-Q · filed 2018-11-09 | $66.16K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-06-30 | $14.34K 10-Q · filed 2018-08-09 | $35.26K 10-Q · filed 2018-08-09 | $55.11K derived: sum of 3 quarters · filed 2019-03-15 | $75.19K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2017-03-31 | $20.92K 10-Q · filed 2018-05-10 | $40.77K derived: sum of 2 quarters · filed 2019-03-15 | $60.85K derived: sum of 3 quarters · filed 2019-03-15 | $80.32K derived: sum of 4 quarters · filed 2019-03-15 | |
| 2016-12-31 | $19.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $39.93K derived: sum of 2 quarters · filed 2019-03-15 | $59.40K derived: sum of 3 quarters · filed 2019-03-15 | $77.52K 10-K · filed 2019-03-15 | |
| 2016-09-30 | $20.08K 10-Q · filed 2017-11-03 | $39.55K derived: sum of 2 quarters · filed 2017-11-03 | $57.67K 10-Q · filed 2017-11-03 | $67.73K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $19.47K 10-Q · filed 2017-08-04 | $37.59K 10-Q · filed 2017-08-04 | $47.65K derived: sum of 3 quarters · filed 2018-03-16 | $64.47K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $18.12K 10-Q · filed 2017-05-15 | $28.18K derived: sum of 2 quarters · filed 2018-03-16 | $45.00K derived: sum of 3 quarters · filed 2018-03-16 | $61.19K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $10.06K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $26.88K derived: sum of 2 quarters · filed 2018-03-16 | $43.07K derived: sum of 3 quarters · filed 2018-03-16 | $53.47K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $16.82K 10-Q · filed 2016-10-28 | $33.01K derived: sum of 2 quarters · filed 2016-10-28 | $43.41K 10-Q · filed 2016-10-28 | $57.53K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | $16.19K 10-Q · filed 2016-07-29 | $26.59K 10-Q · filed 2016-07-29 | $40.71K derived: sum of 3 quarters · filed 2017-03-16 | $55.04K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | $10.39K 10-Q · filed 2016-05-10 | $24.52K derived: sum of 2 quarters · filed 2017-03-16 | $38.85K derived: sum of 3 quarters · filed 2017-03-16 | $46.90K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | $14.13K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $28.45K derived: sum of 2 quarters · filed 2017-03-16 | $36.50K derived: sum of 3 quarters · filed 2017-03-16 | $37.91K 10-K · filed 2017-03-16 | |
| 2014-09-30 | $14.33K 10-Q · filed 2015-10-30 | $22.38K derived: sum of 2 quarters · filed 2015-10-30 | $23.78K 10-Q · filed 2015-10-30 | $25.34K derived: sum of 4 quarters · filed 2016-03-11 | |
| 2014-06-30 | $8.05K 10-Q · filed 2015-08-07 | $9.46K 10-Q · filed 2015-08-07 | $11.02K derived: sum of 3 quarters · filed 2016-03-11 | $11.02K derived: sum of 4 quarters · filed 2016-03-11 | |
| 2014-03-31 | $1.41K 10-Q · filed 2015-05-08 | $2.96K derived: sum of 2 quarters · filed 2016-03-11 | $2.96K derived: sum of 3 quarters · filed 2016-03-11 | $2.96K derived: sum of 4 quarters · filed 2016-03-11 | |
| 2013-12-31 | $1.56K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.56K derived: sum of 2 quarters · filed 2016-03-11 | $1.56K derived: sum of 3 quarters · filed 2016-03-11 | $1.56K 10-K · filed 2016-03-11 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $152.00 derived: sum of 4 quarters · filed 2014-05-12 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-13 | $0.00 10-Q · filed 2013-08-13 | $152.00 derived: sum of 3 quarters · filed 2014-05-12 | $264.00 derived: sum of 4 quarters · filed 2014-05-12 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | $152.00 derived: sum of 2 quarters · filed 2014-05-12 | $264.00 derived: sum of 3 quarters · filed 2014-05-12 | $423.00 derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $152.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $264.00 derived: sum of 2 quarters · filed 2014-02-28 | $423.00 derived: sum of 3 quarters · filed 2014-02-28 | $581.00 10-K · filed 2014-02-28 | |
| 2012-09-30 | $112.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $271.00 derived: sum of 2 quarters · filed 2013-11-14 | $429.00 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $159.00 10-Q · filed 2013-08-13 | $317.00 10-Q · filed 2013-08-13 | |||
| 2012-03-31 | $158.00 10-Q · filed 2013-05-15 | ||||
| 2011-12-31 | $633.00 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |